24 Hrs
Source:
بوابة الشروق
Hossam Abdel Ghaffar on local industry and medicine access
Dr. Hossam Abdel Ghafer, the official spokesperson for the Ministry of Health and Population, confirmed that the state is committed to providing all types of imported insulin, for which there are no local equivalents. He stated that the healthcare insurance system and treatment funded by the government cover the necessary medications. He pointed out that the annual insulin treatment bill amounts to approximately 3.2 billion Egyptian pounds, and local manufacturing of the medicine helps reduce costs and ensure sustainable availability. He explained that the lack of a local equivalent means there is no option to choose between local and imported insulin. The COVID-19 pandemic has also underscored that pharmaceutical security is part of national security, and it requires diversifying sources for importing medications.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)